VEGFA and Hypertension: A recent review asserts that the long-term treatment of oncological patients with anti-VEGF drugs could promote adverse cardiovascular effects through hypertension, suggesting a different mechanism of action of VEGF inhibitors compared to in vitro studies that aim to evaluate the role of angiogenesis within the plaque [37].